Ledger.Open graph →
SEC Form D · filed January 24, 2024

Vaneltix Pharma, Inc

Offering
$5.0M
Sold
$1.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
NEW BRUNSWICK, NJ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Daniel Vickery · New Brunswick, NJExec · DirectorCarlo L. Di Fonzo · Bound Brook, NJDirectorC. L. Parsons · North Brunswick, NJDirectorRobert L. Evans · Bound Brook, NJDirectorDaniel Vickery · New Brunswick, NJExec · DirectorCarlo L. Di Fonzo · Bound Brook, NJDirectorC. L. Parsons · North Brunswick, NJDirectorRobert L. Evans · Bound Brook, NJDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗